In Vitro Diagnostics: World Market Outlook 2012-2022

NEW YORK, Aug. 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

In Vitro Diagnostics: World Market Outlook 2012-2022

http://www.reportlinker.com/p0578540/In-Vitro-Diagnostics-World-Market-Outlook-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Report Details

Our new study shows you potential revenues to 2022 for in vitro diagnostics at total world, submarket and national levels. What technologies and applications will expand that market? What effects will changes have? You will find predictions and answers.

In our report you will find revenue predictions for clinical chemistry, immunochemistry, haematology, microbiology, genetic testing, and point of care testing (POCT).

You will find coverage of Roche, Siemens, Abbott Laboratories, Danaher and Becton Dickinson & Company.

We help you to assess the in vitro diagnostics industry and market's strengths, weaknesses, trends and potential revenues to 2022. You will see where those technologies are heading.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Original analysis with revenues, growth rates, market shares, opinion and discussions

You will find revenue forecasts, growth rates, market shares, a SWOT review, opinions from our survey and discussions of technologies and companies. We provide 68 tables and charts and two research interviews (shown in the accompanying lists).

Why you should buy In Vitro Diagnostics: World Market Outlook 2012-2022

In this report, you will receive the following benefits in particular:• You will discover revenue forecasts to 2021 for the world in vitro diagnostics market and its main components, seeing where the highest revenue growth will occur• You will find revenue forecasts to 2021 for IVD technologies, assessing their commercial potential and applications• You will discover revenue forecasts to 2021 for leading national markets (US, Japan, Germany, France, Spain, UK, Italy, China and India), seeing growth trends• You will assess leading companies in IVD, discovering their activities and outlooks• You will investigate competition and opportunities influencing the IVD industry and market from 2011 onwards• You will see what will stimulate and restrain the IVD industry and market from 2011• You will identify diagnostic needs and commercial opportunities, including those for personalised medicine• You will analyse opportunities and challenges for established companies and those seeking to enter the IVD market• You will view opinions from our industry survey, receiving full interview transcripts.

In Vitro Diagnostics: World Market Outlook 2012-2022 shows you opportunities, challenges and revenue forecasts. That mix of quantitative and qualitative analysis sets our report apart. We tackle crucial questions in the in vitro diagnostics industry and market, aiming to save you time and effort.

You can order this report today

Order our report now to gain industry and market analysis for medical diagnostic tests. Our report is for everybody interested in market analysis, product development, sales and marketing for diagnostic tests and devices. You will find predictions and answers. Don't miss out - please order our report now.

Table of Contents

1.1 Sector Highlights

1.2 Aims, Scope and Format of the Report

1.3 Chapter Outline

1.4 Research and Analysis Methods

1.5 Glossary of Terms Related to the Report

2. Introduction to In Vitro Diagnostics2.1 What are In Vitro Diagnostic (IVD) Tests?2.2 Classifying In Vitro Diagnostics2.2.1 The US Classification2.2.2 The EC (European Commission) Classification2.2.3 Regulatory Issues in the IVD Market2.2.3.1 Regulation of IVD Tests2.2.3.2 Lack Of Clarity Can Be Costly2.3 Types of IVD Tests2.3.1 Point Of Care Diagnostics2.3.2 Clinical Chemistry2.3.3 Microbiology2.3.3.1 Regulatory Differences With IVD Microbiology Tests2.3.4 Haematology2.3.5 Immunochemistry2.3.6 Genetic testing

3. The Global In Vitro Diagnostics Market, 2011-2022

3.1 The Global Medical Devices Market, 2011

3.2 In Vitro Diagnostics Market, 2011

3.3 Global IVD Market Forecast, 2012-2022

3.3.1 IVD Market: Industry Trends, 2012-2022

3.3.1.1 Advances In Technology Driving The IVD Market

3.3.1.2 Decentralisation

3.3.1.3 Increased Awareness Through Globalisation

4. In Vitro Diagnostics Market Sectors, 2011-20224.1 Point-Of-Care Diagnostics4.1.1 POC Diagnostics Market, 20114.1.2 POC Diagnostics: Market Forecast, 2012-20224.1.3 POC Diagnostics: Market Trends, 2012-20224.1.3.1 New Tests Targeting Biomarkers4.1.3.2 Company Competition Driving Product Innovation4.1.3.3 Infectious Diseases Prompting Growth of POC4.2 Clinical Chemistry4.2.1 Clinical Chemistry: Market Forecast, 2012-20224.2.2 Clinical Chemistry: Market Trends, 2012-20224.3 Immunochemistry4.3.1 Immunochemistry: Market Forecast, 2012-20224.3.2 Immunochemistry: Market Trends, 2012-20224.3.2.1 Immunoassays And Automated Systems Prompting Market Growth4.3.2.2 Strong Growth in China and India4.4 Haematology4.4.1 Haematology: Market Forecast, 2012-20224.4.2 Haematology: Market Trends, 2012-20224.5 Microbiology4.5.1 Microbiology: Market Forecast, 2012-20224.5.2 Microbiology: Market Trends, 2012-20224.6 Genetic Testing4.6.1 Genetic Testing: Market Forecast, 2012-20224.6.2 Genetic Testing: Market Trends, 2012-20224.6.2.1 Cytogenetic Tests to Drive Market Growth4.6.2.2 Direct-To-Consumer (DTC) Genetic Screening4.6.2.3 Theranostics: Targeting Unmet Needs Through DNA Tests

5. Leading Companies in the IVD Market

5.1 Fragmented Market

5.2 IVD Market: Breakdown By Company, 2011

5.3 Roche

5.3.1 Sales and Recent Performance Analysis

5.3.1.1.Roche Diagnostics

5.4 Siemens

5.4.1 Sales And Recent Performance Analysis

5.4.1.1 Healthcare Sector

5.5 Danaher

5.5.1 Sales and Recent Performance Analysis

5.5.1.1 Life Sciences & Diagnostics

5.6 Abbott Laboratories

5.6.1 Sales and Recent Performance Analysis

5.7 Becton Dickinson

5.7.1 Sales and Recent Performance Analysis

5.7.1.1 BD Diagnostics

5.8 Other Companies

6. Leading National IVD Markets, 2011-20226.1 Regional Breakdown of The Global IVD Market, 20116.2 The Global IVD Market: Regional Forecast, 2012-20226.3 The US Market6.3.1 Increased Levels of Molecular Testing in The US6.3.2 Increased Use of Mobile Applications6.4 The European Market6.4.1 Germany And France6.4.2 Italy6.4.3 Spain6.4.4 UK6.5 The Japanese Market6.6 The Chinese Market6.7 The Indian Market

7. SWOT Analysis of the IVD Market, 2012

7.1 In Vitro Diagnostics: Industry Trends

7.2 Strengths

7.2.1 Patient Demographics

7.2.2 Technological Advancements

7.3 Weaknesses

7.3.1 Regulatory Board Approvals

7.3.2 Reimbursement Issues

7.4 Opportunities

7.4.1 Globalisation

7.4.2 Molecular Diagnostics

7.5 Threats

7.5.1 Medical Device Excise Tax

7.5.2 Convergence

8. Opinions from Our Industry Survey8.1 Godwin Liu, Marketing Manager, Shenzhen Mindray Bio-Medical Electronics Co.8.1.1 Unmet Needs in the IVD Market8.1.2 Growth in the IVD Sector8.1.3 Challenges Faced by the IVD Market8.1.4 Market Expansion for IVD Products8.2 Interview 2: Director of a Diagnostics Company8.2.1 Most-Promising Therapeutic Areas for IVD8.2.2 Unmet Medical Needs in IVD8.2.3 Greatest Obstacles to Market Growth8.2.4 Prospects for IVD Market Growth in Developing Countries8.2.5 Prospects for Theranostics

9. Conclusions

9.1 Overview

9.2 Point-Of-Care (POC) Testing Will Remain the Largest Segment

9.3 Prominent Companies in the Market

9.4 World Market Forecasts

9.5 Future Outlook and Concluding Remarks

Appendix AAppendix BVisiongain report evaluation form List Of Tables

Table 2.2 Genetic In Vitro Diagnostic Tests Currently Available, 2011

Table 3.1 The Medical Device Market: 2011 Net Sales ($bn), By Sector

Table 3.2 Diagnostic Devices Market: 2011 Net Sales ($bn) and Market Shares (%), By Category

Table 3.3 The IVD Market: 2011 Net Sales ($bn) and Market Shares (%), By Sector

Table 3.4 Global IVD Market Forecast ($bn), By Sector, 2011-2022

Table 4.1 POC Diagnostics: 2011 Net Sales ($bn) & Market Shares (%), By Test

Table 4.2 Point-Of-Care (POC) Diagnostics: Market Forecast ($bn), 2011-2022

Table 4.3 Clinical Chemistry: Market Forecast ($bn), 2011-2022

Table 4.4 Immunochemistry: Market Forecast ($bn), 2011-2022

Table 4.5 Haematology: Market Forecast ($bn), 2011-2022

Table 4.6 Microbiology: Market Forecast ($bn), 2011-2022

Table 4.7 Genetic Testing: Market Forecast ($bn), 2011-2022

Table 5.1 Leading Companies in the IVD Market: 2011 Net Sales ($bn) and Market Shares (%)

Table 5.2 Roche: 2011 Net Sales ($bn) & Market Shares (%), By Sector

Table 5.3 Roche Diagnostics: 2011 Net Sales ($bn) & Market Shares (%), By Product Line

Table 5.4 Siemens: 2011 Net Sales ($bn) and Market Shares (%), By Sector

Table 5.5 Siemens Healthcare Sector: 2011 Net Sales & Percentage Share (%), By Product Group

Table 5.6 Danaher: 2011 Net Sales ($bn) and Market Shares (%), By Sector

Table 5.7 Abbott: 2011 Net Sales ($bn) & Market Shares (%), By Sector

Table 5.8 Becton Dickinson: 2011 Net Sales ($bn) & Market Shares (%), By Sector

Table 5.9 Other Companies Operating in the IVD Market, 2012

Table 6.1 IVD Market: 2011 Sales ($bn) and Market Shares (%), By Region

Table 6.2 IVD Market: Regional Market Forecast ($bn, AGR %, CAGR %), 2011-2022

Table 6.3 The Leading European IVD Market: 2011 Market Value ($bn), European Market Shares (%) and Global Market Shares (%), By Region

Table 6.4 The European IVD Market Forecast ($bn, AGR %, CAGR %) By Region, 2011-2022

Table 7.1 SWOT Analysis of the Global IVD Market, 2012-2022

Table 9.1 IVD Market Forecast ($bn), By Sector In 2011, 2016, 2018 and 2022

List Of Figures

Figure 3.2 Diagnostic Devices Market: 2011 Market Shares (%), By Category

Figure 3.3 IVD Market: 2011 Net Sales ($bn), By Sector

Figure 3.4 IVD Market: 2011 Market Shares (%), By Sector

Figure 3.5 Global IVD Market Forecast ($bn), 2011-2022

Figure 4.1 POC Diagnostics: 2011 Net Sales ($bn), By Test

Figure 4.2 POC Diagnostics: 2011 Market Shares (%), By Test

Figure 4.3 Point-Of-Care (POC) Diagnostics: Market Forecast ($bn), 2011-2022

Figure 4.4 Clinical Chemistry: Market Forecast ($bn), 2011-2022

Figure 4.5 Immunochemistry: Market Forecast ($bn), 2011-2022

Figure 4.6 Haematology: Market Forecast ($bn), 2011-2022

Figure 4.7 Microbiology: Market Forecast ($bn), 2011-2022

Figure 4.8 Genetic Testing: Market Forecast ($bn), 2011-2022

Figure 5.1 Leading Companies in the IVD Market: 2011 Net Sales ($bn)

Figure 5.2 Leading Companies in the IVD Market: 2011 Market Shares (%)

Figure 5.3 Roche: 2011 Market Shares (%), By Sector

Figure 5.4 Roche Diagnostics: 2011 Net Sales ($bn), By Product Line

Figure 5.5 Roche Diagnostics: 2011 Market Shares (%), By Product Line

Figure 5.6 Siemens: 2011 Market Shares (%), By Sector

Figure 5.7 Siemens Healthcare Sector: 2011 Market Shares (%), By Product Group

Figure 5.8 Danaher: 2011 Net Sales ($bn), By Sector

Figure 5.9 Danaher: 2011 Market Shares (%), By Sector

Figure 5.10 Abbott: 2011 Net Sales ($bn) By Sector

Figure 5.11 Abbott: 2011 Market Shares (%), By Sector

Figure 5.12 Becton Dickinson: 2011 Market Shares (%), By Sector

Figure 6.1 IVD Market: 2011 Sales ($bn), By Region

Figure 6.2 IVD Market: 2011 Market Shares (%), By Region

Figure 6.3 The US IVD Market Forecast ($bn), 2011-2022

Figure 6.4 The European IVD Market: 2011 Sales ($bn), By Region

Figure 6.5 The European IVD Market: 2011 Market Shares (%), By Region

Figure 6.6 The European IVD Market Forecast ($bn), 2011-2022

Figure 6.7 The German and French IVD Market Forecasts ($bn), 2011-2022

Figure 6.8 The Italian IVD Market Forecasts ($bn), 2011-2022

Figure 6.9 The Spanish IVD Market Forecasts ($bn), 2011-2022

Figure 6.10 The UK IVD Market Forecasts ($bn), 2011-2022

Figure 6.11 The Japanese IVD Market Forecasts ($bn), 2011-2022

Figure 6.12 The Chinese IVD Market Forecasts ($bn), 2011-2022

Figure 6.13 The Indian IVD Market Forecasts ($bn), 2011-2022

Figure 9.1 Projected IVD Market Growth for 2016, 2018 and 2022, By Sector

Figure 9.2 Projected Total IVD Market Size ($bn) In 2011, 2016, 2018 and 2022

Companies Listed

Abbott Laboratories

Agilent

Alere

Arkray

Bayer

BD Diagnostics

Becton Dickinson

Biomerieux

BioRad

Cardiogenics

Claros Diagnostics

Danaher

Fujirebio

GenProbe

Hologic

Instrumentation Labs

Ipsogen

Johnson & Johnson

Luminex

Mindray

Miraca Life Sciences

Myriad Genetics

Novartis

Polymedco Inc.

Qiagen

Quest Diagnostics

Response Biomedical Corp.

Roche

Saladax

SDIX

Siemens

Sysmex

Transasia Bio Medicals Ltd.

Vermillion

To order this report:In Vitro Diagnostic Industry: In Vitro Diagnostics: World Market Outlook 2012-2022

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

21%

more press release views with 

Request a Demo